NURECABSENureca LtdMediumNeutral
Announced Wed, 28 Jan · 09:48 IST

The Exchange has received the disclosure under Regulation 10(6) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Saurabh Goyal & Others

Ownership Changes View source PDF

NURECA · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve

Awaiting price reaction for this filing.

AI summary

Nureca Limited's promoter group (Saurabh Goyal, Aryan Goyal, Payal Goyal, Smita Goyal, and Nectar Biopharma Pvt Ltd) has filed a disclosure noting a passive increase in their combined shareholding from 64.97% to 68.09%. No shares were actually bought or sold by the promoters. The change happened because the company completed a buyback of 4,58,255 shares (4.58% of total equity) between December 18-24, 2025, with shares extinguished on January 7, 2026. As a result, total outstanding shares dropped from 1,00,00,175 to 95,41,920, automatically lifting each promoter's percentage stake. Saurabh Goyal's holding rose from 32.17% to 33.72%, Payal Goyal's from 20.60% to 21.59%, and Aryan Goyal's from 11.59% to 12.15%. The public shareholding correspondingly fell from 35.03% to 31.91%.

Likely market impact

This is a passive, technical increase in promoter holding caused by the company's own buyback — not any new buying by promoters. Shareholders should note that promoter control has strengthened modestly to 68.09%, while public float has shrunk to 31.91%, which may slightly reduce liquidity in the stock.